about
Adoptive immunotherapy against ovarian cancerPrognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors.The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer.The Prognostic Value of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: a Systematic Review and Meta-analysis.Tumor-infiltrating lymphocytes for the treatment of metastatic cancer.Cellular immunotherapy of cancer: an overview and future directions.Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics.Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies.Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients.The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion.HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer.VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma.Preclinical development of tumor-infiltrating lymphocyte therapy for ovarian cancer.4-1BB-Enhanced Expansion of CD8+ TIL from Triple-Negative Breast Cancer Unveils Mutation-Specific CD8+ T Cells.Impact of neoadjuvant chemotherapy on the immune microenvironment in advanced epithelial ovarian cancer: Prognostic and therapeutic implications.Comparison of clinical utility between neutrophil count and neutrophil-lymphocyte ratio in patients with ovarian cancer: a single institutional experience and a literature review.Maternal CD8+ T-cell depletion alleviates intrauterine inflammation-induced perinatal brain injury.Aging Increases Susceptibility to Ovarian Cancer Metastasis in Murine Allograft Models and Alters Immune Composition of Peritoneal Adipose Tissue.Role of tumor microenvironment in ovarian cancer pathobiology.Improving cancer detection through combinations of cancer and immune biomarkers: a modelling approach.How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment.Sperm Protein 17 Expression by Murine Epithelial Ovarian Cancer Cells and Its Impact on Tumor ProgressionRegulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor MicroenvironmentPrognostic Role of Platelet-to-Lymphocyte Ratio in Hepatocellular Carcinoma with Different BCLC Stages: A Systematic Review and Meta-Analysis
P2860
Q26748905-06350510-A20D-4770-B187-29D6C6FB71EFQ33591683-BD027BEE-38FC-4D18-81C6-FFFFA42C4821Q37716589-1160EF35-145E-4C0C-9457-1C08F723462FQ38633171-0680903D-C5B8-4D72-A92A-3EC038DE9347Q38636573-A5311D59-614F-423D-8016-6A06D3AE1C21Q38673161-8158E188-74BB-4DC4-81C7-FEF6A51A2FAEQ38998423-128FC957-B361-47E9-8D40-0A2FB7FAE8D6Q39178061-0B479F4F-B2F3-4B8F-9BA4-073DF44EEB94Q40424694-84F050F8-EF81-415C-A109-5871DB5EBD3DQ41141854-95AAEEF5-7A73-4CE9-9E11-B48BD8777B94Q41431266-FF6D4867-844C-4E29-B0D7-FE0F8D04363AQ41636554-7815B376-35FF-47F8-BAE5-098547D1B47FQ45896503-FE844FBD-14F5-4D42-88EB-5FB64A84DAFCQ46863819-BC5DBC2C-6E34-4F5B-AAD6-92401491DA83Q47346032-27BBBD0F-7841-480F-A476-EA108F42637CQ47915260-7B466AA2-4D02-44CC-9190-3E292E7FCE32Q47932843-F1ED0D9E-DC47-4D51-B463-A15D12F02D01Q55074255-30374F3F-AA8B-4C1C-A912-6A57B9556B6DQ55078149-8F9C4651-FEB3-4698-9BF7-F3E9E1CFF550Q55297626-2378A3C6-6355-4CFF-9BDC-05E545CBBF7CQ55316580-6D65F6C5-DBE6-4BEB-8637-0FBE2A734135Q56889963-A8EF92E5-16DF-4127-8D6B-B739C4161815Q58773649-4ABEFFC5-38F5-4D28-AC88-497325F15310Q58795219-58E874DA-97D0-459F-8470-ED55EC36AB87
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Tumor infiltrating lymphocytes in ovarian cancer
@ast
Tumor infiltrating lymphocytes in ovarian cancer
@en
Tumor infiltrating lymphocytes in ovarian cancer
@nl
type
label
Tumor infiltrating lymphocytes in ovarian cancer
@ast
Tumor infiltrating lymphocytes in ovarian cancer
@en
Tumor infiltrating lymphocytes in ovarian cancer
@nl
prefLabel
Tumor infiltrating lymphocytes in ovarian cancer
@ast
Tumor infiltrating lymphocytes in ovarian cancer
@en
Tumor infiltrating lymphocytes in ovarian cancer
@nl
P2860
P3181
P1476
Tumor infiltrating lymphocytes in ovarian cancer
@en
P2093
Daniel J Powell
Phillip P Santoiemma
P2860
P304
P3181
P356
10.1080/15384047.2015.1040960
P407
P577
2015-01-01T00:00:00Z